We also found an increased viability of KYSE150 cells in the HF and SC-79 co-treatment group compared with HF alone treatment (Figure 5F), suggesting that activation of AKT attenuated the ability of HF to inhibit cell proliferation. The gene discussed is AKT1; the disease is hydrops fetalis.